The Clinico-Multiomic Intelligence.
Unlock actionable clinical insights through a 360° view of the molecular biology underlying your study.
Today’s offerings: RESEARCH SERVICES | PLUG & PLAY ANALYSIS KITS
The Problem: A Fragmented View of Multi-Omic Reality
Biology is a symphony of countless molecular interactions happening in concert. Yet, most research, drug target discovery, and precision medicine programs are forced to rely on limited, 1-dimensional data.
The complete view of underlying biology remains hidden because of three critical barriers:
- High Costs & Limited Samples: Multi-omic experiments are often too expensive or require more biological material than clinical reality allows.
- The Expertise Gap: Integrating complex datasets and matching with/mining existing clinico-omic data requires specialized bioinformatic skills that are rare, expensive, and create constant bottlenecks.
- Buried Intelligence: The best ML models and tools to extract advanced features or patterns from omic data are often trapped in academic papers—undeployed, unoptimized, and inaccessible to active labs that need them the most.
Our Solution: A Unified Clinico-Multiomic Ecosystem
Bainom bridges the gap between raw clinical and/or omic data and clinically actionable insights by unifying industry-standard bioinformatic tools, interpretive ML models, a dynamic clinical knowledgebase, and a global data tensor of pre-extracted omic features for every major disease condition.
Combined with our deep expertise, this powerful infrastructure provides a 360-degree view of your study’s molecular biology by transforming raw data into prioritized, clinically actionable discoveries. By breaking down data and tech silos, we empower deep discovery, precision medicine initiatives, as well as novel drug target and biomarker identification.
What You Get
1
Core processing: Instantly standardize and convert your raw data for downstream discovery. No need to spend weeks in learning, troubleshooting bioinformatic pipelines. Our automated pipelines execute quality control, alignment, and feature extraction to build a clean, reproducible foundation.
We currently support: RNA-Seq | ATAC-Seq | ChIP-Seq | Microbiome | Proteomic | RNA-Protein Interactions (CLIP) | Spatial | scRNA | Clinical | Custom Omic Methods
2
DeepInsight Advanced Workflows: Uncover advanced features from your omic data. Go beyond standard analysis with workflows, tools, and ML models carefully curated from 1000s of top-tier scientific articles. We have deployed these validated frameworks in our cloud to readily extract hidden biological patterns from your existing data.
e.g., from bulk RNA-Seq: immune deconvolution, gene correlation network, other RNA types, alternative splicing; from single-cell RNA-Seq: cell-cell communication)
3
Clinico-Multiomic Integration: Gain a complete molecular picture through a unified view of your study datasets.
- (a) Clinico-Multiomic Fusion: Integrate multiple omic layers directly with clinical data using state-of-the-art proprietary and open-source ML models.
- (b) Single-to-Multiomic Expansion: Match isolated profiles with our data infrastructure to transform your single-omic data into a 360-degree multiomic view.
4
Tensor Mining & Sample Stratification: Maximize the value of global biomedical knowledge without leaving your workspace.
- (a) Repository Mining: Explore and mine pre-extracted data from massive public repositories like UK Biobank, GEO, and TCGA to find immediate insights.
- (b) Cohort Stratification: Match your specific study profiles against existing patient cohorts to subtype samples, map disease states, and discover novel biomarkers.
5
Clinical Action & Reporting: Move directly from complex multiomic data matrices to validated medical insights.
- (a) Feature Prioritization: Validate, shortlist, and rank extracted features by biological significance using AI-based attention-scoring, and training/testing ML models.
- (b) Evidence-Backed Reporting: Instantly generate a comprehensive report mapping your top features to established clinical guidelines, active cinical trials, case studies, peer-reviewed literature, and predictive ML models.
Today’s Offerings
01
RESEARCH SERVICES
Your dedicated analytical partner for clinico-multiomics.
Get full-stack or specialized, short-term bioinformatics support for processing, multiomic integration, ML modeling, interpretation, and manuscript preparation. Ideal for labs needing flexible analytical bandwidth without hiring a full-time computational biologist.
Best for: Biotech startups, translational biology labs, clinical researchers, and mechanistic biology groups.
How it works: Describe your project, propose your price, and receive a customized Statement of Work (SOW).
02
PLUG & PLAY ANALYSIS KITS
Reproducible omic workflows & interpretive ML models ready to run today.
Deploy standardized processing flows for RNA-seq, scRNA-seq, spatial, proteomics and more. Leverage our proprietary ML models to shortlist features, predict clinical response, and stratify patients with zero scope creep.
How it works: Choose a pre-configured analysis kit, purchase instantly via secure payment, and get results within a week or less.
Why Bainom?
Proven Scientific Expertise: Built by researchers with 20+ years in clinico‑multiomics and publications across top journals (Nature, Cell, JCI, PLoS). Bainom pairs deep scientific expertise with modern computational engineering to deliver analysis that meets peer‑review standards.
Reproducible From Day One: Every workflow is fully containerized (Nextflow/Docker), ensuring consistent, audit‑ready runs. Your Methods sections are ready on Day 1, and every analysis is traceable, repeatable, and easy to extend across new datasets.
Frictionless Procurement: Productized pricing fits standard university P‑Card limits and common hospital/biotech purchasing workflows. Options for custom contracts and traditional purchase orders (PO).
Universal Flex-Credits: Reserve budget once, use it whenever your data is ready. Credits never expire and apply to any plug-and-play kit or to request our hand-on service — ideal for unpredictable wet‑lab timelines and grant‑driven workloads.